Table 2 |
||||
|
Treatment items before, during and after treatment of DKA |
||||
|
Treatment items |
Time (h) after admission |
|||
|
|
||||
|
0 |
10 |
24 |
44 |
|
|
net fluid gain* (ml/kg) |
10 |
13 |
83 |
116 |
|
GCS**score (3-15) |
12 |
8 |
not applicable |
15 |
|
Artificial ventilation -/+ |
--- |
-- < ++++ |
++++++++++ |
++++ > --- |
|
Octreotide infusion (μg/kg/h) |
0 |
0 |
3.5 |
1.8 |
|
Insulin infusion (U/kg/h) |
0.1 |
0.1 |
0.05 |
0.025 |
|
|
||||
|
*total intravenous fluids minus urinary output; **GCS = Glasgow Coma Scale |
||||
|
Seewi et al. Diabetology & Metabolic Syndrome 2010 2:56 doi:10.1186/1758-5996-2-56 |
||||
